Pershing Square Capital Management's billionaire chief has sold most of his fund's stake in Chipotle over seven years, and is ...

Just weeks after its landmark 50-for-1 stock split made shares more affordable for employees and a broader base of investors, ...

In the latest close session, Onto Innovation (ONTO) was down 1.08% at $101.76. This change lagged the S&P 500's 0.33% loss on the day. Meanwhile, the Dow experienced a drop of 0.63%, and the ...

HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...

Federated Hermes shines with an asset-light model, strong AUM growth, 3% yield, private market moves, and value-driven ...

The dual circulation jointly built by Shanghai and Hong Kong as the country's two currency hubs is especially important in ...

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

Use of tools like Claude AI to analyse portfolios and get buy and sell stock recommendations pose a new challenge for advisors and investment managers.

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.

Meta’s $100 million sign-up bonuses have underscored the value of cutting-edge tech talent. Indian businesses should also be ...

We came across a bullish thesis on Lockheed Martin Corporation on Stock Region Research’s Substack by Stock Region. In this ...